Artikkeltips

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. 
Russell, M. D., Dey, M., Flint, J., Davie, P., Allen, A., Crossley, A., Frishman, M., Gayed, M., Hodson, K., Khamashta, M., Moore, L., Panchal, S., Piper, M., Reid, C., Saxby, K., Schreiber, K., Senvar, N., Tosounidou, S., van de Venne, M., . . . Giles, I. (2022). Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keac551. PMID: 36318966

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice. 
Schreiber, K., Frishman, M., Russell, M. D., Dey, M., Flint, J., Allen, A., Crossley, A., Gayed, M., Hodson, K., Khamashta, M., Moore, L., Panchal, S., Piper, M., Reid, C., Saxby, K., Senvar, N., Tosounidou, S., van de Venne, M., Warburton, L., . . . Giles, I. (2022). Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keac552. PMID: 36318967

Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases.
Andreoli L, Chighizola CB, Iaccarino L, Botta A, Gerosa M, Ramoni V, Tani C, Bermas B, Brucato A, Buyon J, Cetin I, Chambers CD, Clowse MEB, Costedoat-Chalumeau N, Cutolo M, De Carolis S, Dolhain R, Fazzi EM, Förger F, Giles I, Haase I, Khamashta M, Levy RA, Meroni PL, Mosca M, Nelson-Piercy C, Raio L, Salmon J, Villiger P, Wahren-Herlenius M, Wallenius M, Zanardini C, Shoenfeld Y, Tincani A.  Autoimmun Rev. 2022 Dec 20;22(3):103259. doi: 10.1016/j.autrev.2022.103259. Epub ahead of print. PMID: 36549355.

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy.
Ghalandari N, Kemper E, Crijns IH, Wolbink G, Rispens T, Smeele HT, Dolhain RJ.
Ann Rheum Dis. 2022 Mar;81(3):402-405. doi: 10.1136/annrheumdis-2021-221036. Epub 2021 Sep 7. PMID: 34493490.

Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis. 
O'Byrne, L. J., Alqatari, S. G., Maher, G. M., O'Sullivan, A. M., Khashan, A. S., Murphy, G. P., & McCarthy, F. P. (2022). Bjog, 129(8), 1236-1246. https://doi.org/10.1111/1471-0528.17093. PMID: 35014759.

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
Arthritis Rheumatol. Sammaritano LR et al. 2020 Apr;72(4):529-556. doi: 10.1002/art.41191. Epub 2020 Feb 23. PMID: 32090480.

A systematic review of the safety of non-tumour necrosis factor inhibitor and targeted synthetic drugs in rheumatic disease in pregnancy.
Ahmed K et al. 2020 Mar;20(Suppl 2):s98. doi: 10.7861/clinmed.20-2-s98. PMID: 32409405.

The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.
Perez-Garcia LF, Dolhain RJEM, Vorstenbosch S, Bramer W, van Puijenbroek E, Hazes JMW, Te Winkel B. Hum Reprod Update. 2020 Nov 1;26(6):961-1001. doi: 10.1093/humupd/dmaa022. PMID: 32743663.

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
Götestam Skorpen C et al.Ann Rheum Dis. 2016 May;75(5):795-810. doi: 10.1136/annrheumdis-2015-208840. Epub 2016 Feb 17. PMID: 26888948.

Risk of Ocular Anomalies in Children Exposed In Utero to Antimalarials: A Systematic Literature Review.
Gaffar R et al. Arthritis Care Res (Hoboken). 2019 Dec;71(12):1606-1610. doi: 10.1002/acr.23808. PMID: 30418703.

Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence.
Mouyis M et al. Semin Arthritis Rheum. 2019 Apr;48(5):911-920. doi: 10.1016/j.semarthrit.2018.07.011. Epub 2018 Aug 17. PMID: 30220537.

Systemic Lupus Erythematosus Management in Pregnancy.
Dao, K. H., & Bermas, B. L. (2022). Int J Womens Health, 14, 199-211. https://doi.org/10.2147/ijwh.S282604. PMID: 35210867.

Svangerskapskomplikasjoner hos kvinner med systemisk lupus erythematosus [Pregnancy complications in women with systemic lupus erythematosus].
Skorpen CG, Salvesen KÅB, Palm Ø, Radtke M, Wallenius M. Tidsskr Nor Laegeforen. 2021 May 25;141(8). Norwegian. doi: 10.4045/tidsskr.20.0596. PMID: 34047174.

Pregnancy outcomes in mixed connective tissue disease: a multicentre study.
Radin M, Schreiber K, Cuadrado MJ, Cecchi I, Andreoli L, Franceschini F, Caleiro T, Andrade D, Gibbone E, Khamashta M, Buyon J, Izmirly P, Aguirre MA, Benedetto C, Roccatello D, Marozio L, Sciascia S. Rheumatology (Oxford). 2019 Nov 1;58(11):2000-2008. doi: 10.1093/rheumatology/kez141. PMID: 31079145.

Pregnancy and undifferentiated connective tissue disease: outcome and risk of flare in 100 pregnancies.
Zucchi D et al. Rheumatology (Oxford). 2020 Jun 1;59(6):1335-1339. doi: 10.1093/rheumatology/kez440. PMID: 31593595.

Maternal and fetal complications associated with systemic lupus erythematosus: An updated meta-analysis of the most recent studies (2017-2019).
He WR, Wei H. Medicine (Baltimore). 2020 Apr;99(16):e19797. doi: 10.1097/MD.0000000000019797. PMID: 32311994.

Not only disease activity but also chronic hypertension and overweight are determinants of pregnancy outcomes in patients with systemic lupus erythematosus. Normand G et al. Lupus. 2019 Apr;28(4):529-537. doi: 10.1177/0961203319832097. Epub 2019 Feb 24. PMID: 30799679.

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.
Andreoli L et al. Ann Rheum Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul 25. PMID: 27457513.

Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study.
Skorpen CG et al.  Ann Rheum Dis. 2018 Feb;77(2):264-269. doi: 10.1136/annrheumdis-2017-211641. Epub 2017 Nov 1. PMID: 29092851.

Disease Activity During Pregnancy and the First Year Postpartum in Women With Systemic Lupus Erythematosus.
Götestam Skorpen C et al. Arthritis Care Res (Hoboken). 2017 Aug;69(8):1201-1208. doi: 10.1002/acr.23102. Epub 2017 Jul 10. PMID: 27696790.

A population-based study of caesarean section in women with juvenile idiopathic arthritis. 
Götestam Skorpen C, Lydersen S, Salvesen KÅ, Wallenius MRheumatol Adv Pract. 2023 Jul 28;7(2):rkad062. doi: 10.1093/rap/rkad062. PMID: 37600477.

Caesarean section in women with axial spondyloarthritis and psoriatic arthritis: a population-based study.
Götestam Skorpen C, Lydersen S, Salvesen KÅ, Koksvik HSS, Jakobsen B, Wallenius M. RMD Open. 2023 Mar;9(1):e002760. doi: 10.1136/rmdopen-2022-002760. PMID: 36863750.

Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP).
Meissner, Y., Strangfeld, A., Molto, A., Forger, F., Wallenius, M., Costedoat-Chalumeau, N., Bjørngaard, H., Couderc, M., Flipo, R. M., Guettrot-Imbert, G., Haase, I., Jakobsen, B., Koksvik, H. S. S., Richez, C., Sellam, J., Weiß, A., Zbinden, A., & Fischer-Betz, R. (2022).  Ann Rheum Dis. https://doi.org/10.1136/ard-2022-222641. PMID: 35961759. 

Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark. Rheumatology(2022).
Hellgren K, Secher AE, Glintborg B, Rom AL, Gudbjornsson B, Michelsen B, Granath F, Hetland ML. (Oxford). 2022 Aug 30;61(9):3711-3722. doi: 10.1093/rheumatology/keab894. PMID: 34864891.

Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study.
Smeele HT et al. 2021 Jul;80(7):859-864. doi: 10.1136/annrheumdis-2020-219547. Epub 2021 Feb 10. PMID: 33568387.

Psoriatic Arthritis Disease Activity During and After Pregnancy: A Prospective Multicenter Study.
Ursin K et al. Arthritis Care Res (Hoboken). 2019 Aug;71(8):1092-1100. doi: 10.1002/acr.23747. Epub 2019 Jul 9. PMID: 30192071.

Disease activity during and after pregnancy in women with axial spondyloarthritis: a prospective multicentre study.
Ursin K et al. Rheumatology (Oxford). 2018 Jun 1;57(6):1064-1071. doi: 10.1093/rheumatology/key047. PMID: 29554329.

Disease Activity of Juvenile Idiopathic Arthritis during and after Pregnancy: A Prospective Multicenter Study.
Ursin K et al. J Rheumatol. 2018 Feb;45(2):257-265. doi: 10.3899/jrheum.161410. Epub 2017 Dec 1. PMID: 29196380.

A comprehensive guide for managing the reproductive health of patients with vasculitis.
Sims, C., & Clowse, M. E. B. (2022). Nat Rev Rheumatol, 1-13. https://doi.org/10.1038/s41584-022-00842-z. PMID: 36192559.

Pregnancy Outcomes in Systemic Vasculitides.
Ross C et al. Curr Rheumatol Rep. 2020 Aug 26;22(10):63. doi: 10.1007/s11926-020-00940-5. PMID: 32845412.

Takayasu Arteritis and Pregnancy: A Population-Based Study on Outcomes and Mother/Child-Related Concerns.
Gudbrandsson B et al. Arthritis Care Res (Hoboken). 2017 Sep;69(9):1384-1390. doi: 10.1002/acr.23146. Epub 2017 Aug 8. PMID: 27813289.

EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG et al. Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15. PMID: 31092409.

Management of antiphospholipid syndrome.
Uthman I et al. Ann Rheum Dis. 2019 Feb;78(2):155-161. doi: 10.1136/annrheumdis-2018-213846. Epub 2018 Oct 3. PMID: 30282668.

Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patients. Sigmo GD, Hauge S, Hufthammer KO, Wallenius M, Salvesen KÅ, Daltveit AKN, Bakland G, Fevang BS. Ann Rheum Dis. 2024 Mar 12;83(4):457-463. doi: 10.1136/ard-2023-224998. PMID: 38262688.

Factors associated with time to pregnancy in women with axial spondyloarthritis: A registry-based multicenter study.
Ursin K et al. Arthritis Care Res (Hoboken). 2020 Apr 30. doi: 10.1002/acr.24233. Epub ahead of print. PMID: 32353185.

Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study.
Nørgård BM et al. Ann Rheum Dis. 2019 Mar;78(3):328-334. doi: 10.1136/annrheumdis-2018-214619. Epub 2019 Jan 12. PMID: 30636215.

Women with systemic lupus erythematosus get pregnant more easily than women with rheumatoid arthritis.
Götestam Skorpen C et al. Rheumatology (Oxford). 2018 Jun 1;57(6):1072-1079. doi: 10.1093/rheumatology/key049. PMID: 29554346.

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
Arthritis Rheumatol. Sammaritano LR et al. 2020 Apr;72(4):529-556. doi: 10.1002/art.41191. Epub 2020 Feb 23. PMID: 32090480.

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.
Andreoli L et al. Ann Rheum Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul 25. PMID: 27457513.

Sist oppdatert 15.03.2024